**Contents**



The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1*H*-Indole Derivative: In Silico and In Vitro Approaches Reprinted from: *Processes* **2022**, *10*, 1391, doi:10.3390/pr10071391 ................... **140**
